. 2021 Jul 19;6(29):19202–19211. doi: 10.1021/acsomega.1c02549
© 2021 The Authors. Published by American
Chemical Society
Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1.
Currently used AChE inhibitors as anti-AD drugs.